Many studies have focused on osteoprotegerin (OPG), a receptor activator of nuclear factor κB (RANK) and RANK ligand (RANKL), in cholesteatoma-related bone erosion (Jeong et al., 2006; Kuczkowski et al., 2010; Likus et al., 2016). Here, TNFRSF11B is linked to cholesteatoma.